CNS Pharma partners with MD Anderson
May 29, 2020 -- Cancer biopharmaceutical company CNS Pharmaceuticals has entered into a sponsored research agreement with the University of Texas MD Anderson Cancer Center to investigate cancer treatment technologies.
Merck, Ridgeback Bio partner on COVID-19 antiviral
May 26, 2020 -- Merck and Ridgeback Biotherapeutics announced that they have entered a collaboration to develop EIDD-2801, an orally available antiviral candidate in early clinical development for treatment of patients with COVID-19.
Thermo releases spectrometry products for proteomics
May 26, 2020 -- Thermo Fisher Scientific has announced an exclusive license agreement with software firm MSAID for intelligent software that uses deep learning facilitated by a neural network called Prosit. The company also announced that it is continuing an existing collaboration with Biognosys to advance data-independent acquisition mass spectrometry-based workflows.
City of Hope sponsors COVID-19 research
May 22, 2020 -- City of Hope released details of multiple COVID-19 research projects, including the development of two potential vaccines, new therapies, and better screening approaches.
Atomwise pursues 15 collaborations for COVID-19 treatments
May 22, 2020 -- Small molecule drug discovery company Atomwise has announced it is collaborating with 15 institutions to develop broad-spectrum therapies for coronaviruses, including the novel coronavirus responsible for COVID-19.
Vividion, Roche partner for small-molecule drug discovery
May 19, 2020 -- Biotechnology company Vividion Therapeutics has signed an exclusive worldwide option and license agreement with Roche.
Roche becomes founding partner of biotech accelerator
May 15, 2020 -- Roche has become a founding partner in the second phase of development of BaseLaunch, a Basel, Switzerland-based incubator and accelerator that helps scientists and entrepreneurs launch biotech companies.
Bio-Rad posts increased Q1 revenue during pandemic
May 8, 2020 -- For the quarter revenue increased to $571.6 million, compared with $554 million in the first quarter of 2019. Meanwhile, net income in the first quarter plummeted to $685.9 million from approximately $865 million in the same quarter a year ago.
PerkinElmer Q1 revenues edge up, profit edges down
May 8, 2020 -- In financial results for the first quarter, PerkinElmer saw revenues grow slightly, but net income slipped.
Danaher announces chief executive transition
May 7, 2020 -- Danaher announced on May 6 that Executive Vice President Rainer Blair will succeed Thomas Joyce Jr. as president and CEO when Joyce retires on September 1.
Conferences
2nd Annual Cell Therapy Bioprocessing Conference
June 25-26
Boston, Massachusetts United States
BioProcess International Europe
July 13-16
Amsterdam, Noord-Holland Netherlands
Bioprocess International West
August 10-13
Santa Clara, California United States
General Discussion
Topic Replies / Views Last Update
https://academic.oup.com/ve/pages/coronavirus-evolution
by Michael
0 / 29 More than 3 days ago
by Michael
PopSci Hails Impossible Burger 2.0 as Most Important Engineering Innovation in 2019
by Mahesh Gupta
0 / 11 More than 3 days ago
by Mahesh Gupta
Engineered Bacteria Produces BeeFree Honey
by Mahesh Gupta
0 / 12 More than 3 days ago
by Mahesh Gupta
Consumers' Preference to Buy Unlabeled Produce Increases after Exposure to GMO-labeled Pro
by Mahesh Gupta
0 / 15 More than 3 days ago
by Mahesh Gupta
Super-precise new CRISPR tool could tackle a plethora of genetic diseases
by Mahesh Gupta
0 / 14 More than 3 days ago
by Mahesh Gupta
To see more posts from our community or to share a post of your own, go to our community's forum page.
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter